ZIC2 and neoplasm: The control vector-transfected CTBPH1 cells exhibited aggressive growth, while the MTF1 knockdown and ZIC2 CRISPR/cas9 knockout cells significantly inhibited tumor growth and reduced tumor weight (Fig. 7C - E).